Cargando…

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is mostly resistant to standard chemotherapy that results in poor patient survival. To understand the genetic background of these tumours, we performed whole-genome sequencing of OCCC tumours. METHODS: Tumour tissue samples and matched blood samples we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itamochi, Hiroaki, Oishi, Tetsuro, Oumi, Nao, Takeuchi, Satoshi, Yoshihara, Kosuke, Mikami, Mikio, Yaegashi, Nobuo, Terao, Yasuhisa, Takehara, Kazuhiro, Ushijima, Kimio, Watari, Hidemichi, Aoki, Daisuke, Kimura, Tadashi, Nakamura, Toshiaki, Yokoyama, Yoshihito, Kigawa, Junzo, Sugiyama, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Genetics & Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572180/ https://www.ncbi.nlm.nih.gov/pubmed/28728166 http://dx.doi.org/10.1038/bjc.2017.228

Ejemplares similares

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer
por: Takehara, Kazuhiro, et al.
Publicado: (2021)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Chemotherapy and molecular targeting therapy for recurrent cervical cancer
por: Tsuda, Naotake, et al.
Publicado: (2016)

Lymphadenectomy issues in endometrial cancer
por: Konno, Yosuke, et al.
Publicado: (2021)

Nedaplatin: a cisplatin derivative in cancer chemotherapy
por: Shimada, Muneaki, et al.
Publicado: (2013)

Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
por: SHIMADA, MUNEAKI, et al.
Publicado: (2013)

Synergistic Enhancement of Cisplatin Cytotoxicity by SN‐38, an Active Metabolite of CPT‐11, for Cisplatin‐resistant HeLa Cells
por: Minagawa, Yukihisa, et al.
Publicado: (1994)

Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer
por: Nishio, Shin, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival
por: Matsuo, Koji, et al.
Publicado: (2019)

Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group)
por: Seki, Toshiyuki, et al.
Publicado: (2023)

An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023
por: Shoji, Tadahiro, et al.
Publicado: (2018)

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines
por: Minagawa, Yukihisa, et al.
Publicado: (1997)

Cisplatin‐resistant HeLa Cells Are Resistant to Apoptosis via p53‐dependent and ‐independent Pathways
por: Minagawa, Yukihisa, et al.
Publicado: (1999)

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
por: Saito, Toshiaki, et al.
Publicado: (2017)

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002)

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study
por: Yoshihara, Kosuke, et al.
Publicado: (2020)

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program
por: Matsumoto, Koji, et al.
Publicado: (2019)

Implementation of primary HPV testing in Japan
por: Kurokawa, Tetsuji, et al.
Publicado: (2020)

Surgical management of non-invasive uterine clear cell carcinoma
por: Sugiyama, Toru, et al.
Publicado: (2017)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
por: Asano, Hiroshi, et al.
Publicado: (2022)

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)
por: Hamanishi, Junzo, et al.
Publicado: (2021)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006)

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma
por: Miyata, Kohei, et al.
Publicado: (2014)

Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Kobayashi, Yusuke, et al.
Publicado: (2022)

A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial
por: Hori, Kensuke, et al.
Publicado: (2021)

Improvement of Intraperitoneal Chemotherapy for Rat Ovarian Cancer Using Cisplatin‐containing Microspheres
por: Kumagai, Seisuke, et al.
Publicado: (1996)

Treatment for Recurrent Ovarian Cancer—At First Relapse
por: Ushijima, Kimio
Publicado: (2010)

ASGO's Third Biennial Meeting, December 12-14, 2013
por: Ushijima, Kimio
Publicado: (2014)

Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy
por: Ushijima, Kimio
Publicado: (2019)

Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups
por: Todo, Yukiharu, et al.
Publicado: (2016)

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
por: Shoji, Tadahiro, et al.
Publicado: (2014)

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
por: Murakami, Isao, et al.
Publicado: (2023)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
por: Mikami, Mikio, et al.
Publicado: (2017)

lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer
por: Horita, Kosuke, et al.
Publicado: (2019)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Nogami, Yuya, et al.
Publicado: (2021)

Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0fjglo18osh4eob6jqcj6sp4qa